Opipramol dihydrochloride

Product description

Therapeutic Area: Nervous System
  • EU DMF available

Indication: Atypical tricyclic antidepressant and anxiolytic agent. It exhibits no reuptake inhibiting properties, but rather acts as an antagonist at D2, 5-HT2 and H1 receptors and binds with high affinity to sigma1 and sigma2 receptors (Ki value of 50 nM). The anxiolytic effects are believed to be mediated primarily via the sigma2 receptor.

Read more


Categories Contract Services - Contract ServicesContract Manufacturing
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; Africa; Central/South America
Supplied from Poland
Measured In g; Kgs

More products from ZF Polpharma SA

View all our products (32)

Products from other suppliers

Opipramol dihydrochloride

Contact information




View all contact information